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Introduction
Oxidative stress has been a major topic for
many years [1]. The role of free radicals in aging
in fact, has been often studied. It is assumed that
during aging, damaging effects of the oxygen free
radicals may be accumulated in all components of
the body. In fact, Reactive Oxygen Species (ROS)
are normally generated by tightly regulated en-
zymes, such as NAD (P) H oxydase isoforms [2].
An overproduction of ROS is related to damage of
cell structures such as lipids, proteins and DNA
[2]. However, ROS are not only the cause of struc-
tural damage, but they are also physiologically im-
portant mediators in biological signalling process-
es, such as apoptosis [3].
During aging, the progressive deficit of anti-
oxidant physiologic systems corresponds to this
increase of free radicals, leading to an altered bal-
ance of oxidants/anti-oxidants that is one of the
pathological mechanisms of many age-dependent
disorders [4-6].
The role of ROS in lung diseases has been of-
ten studied. Lungs are continuously exposed to ox-
idants generated either endogenously or exoge-
nously from air pollutants or cigarette smoke [7].
Cigarette smoke can damage lungs by various
mechanisms such as depletion of glutathione and
other anti-oxidants or initiation of redox cycling
mechanisms [7]. The oxidation of proteins has an
important role in the pathogenesis of chronic in-
flammatory lung diseases, such as Chronic Ob-
structive Pulmonary Disease (COPD), but high
plasmatic levels of ROS have also been demon-
strated in cystic fibrosis, asbestosis and idiopathic
pulmonary fibrosis [8-10].
Lung inflammation has been found in healthy
subjects during aging, as demonstrated by the in-
crease of neutrophils in induced sputum of these
subjects [11]. Oxidative stress is strictly related to
lung inflammation because the recruited inflam-
matory cells are able to release free radicals, re-
sponsible for tissue damage [12, 13].
Usually, ROS are measured by assessing the
plasmatic derivatives of reactive oxygen metabolites
(D-ROMS). However, the possibility that the oxida-
tive stress is also present in airways has been recent-
ly suggested [14, 15]. In the last decade, the interest
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Background. An altered balance of oxidants/anti-oxi-
dants is one of the pathological mechanisms of many age-
dependent disorders. We aimed to investigate the age-re-
lated airways oxidative stress, using non invasive, safe and
repeatable techniques; to evaluate the correspondence be-
tween systemic and local oxidative stress in healthy sub-
jects of different age ranges; to analyse the correlation be-
tween systemic and local oxidative stress with lung func-
tion and with cognitive impairment.
Methods. Thirty consecutive healthy high school grad-
uated subjects (8 M, 22 F), divided in three ranges of age
(<35; between 35 and 60; >60 years) were enrolled. All
subjects underwent oxygen free radicals and exhaled ni-
tric oxide measurement (by the diacron reactive oxygen
metabolites test and by a rapid-response chemilumines-
cence nitric oxide analyzer), lung function tests, and cog-
nitive impairment scales (Mini Mental State Examination
and Geriatric Depression Scale).
Results. A significant increase of oxygen free radicals,
exhaled nitric oxide, and Geriatric Depression Scale score
and a significant decrease of forced expiratory volume in
1 second and forced expiratory vital capacity from
younger to older subjects were identified. Moreover, the
significant positive correlation between oxygen free radi-
cals and exhaled nitric oxide, and between oxygen free
radicals and exhaled nitric oxide with Geriatric Depres-
sion Scale score were found. The significant negative cor-
relation between forced expiratory volume in 1 second and
oxygen free radicals or exhaled nitric oxide was also
demonstrated.
Conclusions. Our data supports the role of progres-
sive local oxidative stress in damaging the lung function
and in inducing depression symptoms.
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in studying airways using non invasive methods,
such as induced sputum, exhaled NO and exhaled
breath condensate has increased [11, 16]. These com-
pletely non-invasive, safe and repeatable techniques,
are ideal to study lung inflammation parameters such
as exhaled nitric oxide (NO) in the elderly.
Moreover, aging is known to be accompanied
by the decrease of respiratory function, charac-
terised by a progressive decrease of the dynamic
indices (forced expiratory volume in 1 second 
- FEV1 - and forced expiratory vital capacity -
FVC), probably due, at least in part, to airways in-
flammation and oxidative stress [17]. To our
knowledge, this interesting possible association
has been poorly investigated.
Aging process is also characterised by the de-
cline of cognitive functions. The role of oxygen
radicals and ROS in neurodegeneration and cogni-
tive decline has been demonstrated previously [18-
20]. The age-related increase in oxidative brain
damage is well exemplified by products of lipid
peroxidation, protein oxidation and oxidative mod-
ifications in nuclear and mithocondrial DNA [21].
In animal models, the age-related decline in
memory function has been ameliorated by N-
acetyl-cysteine (NAC), which increases the avail-
ability of cellular anti-oxydants, such as cysteine
and intracellular GSH [22, 23].
However, few studies on humans are available.
Ultraoctagenarian population was analysed by
Maugeri et al [4] in order to reveal a possible cor-
relation between the free radical levels and the
psycho-physical health status. The statistically sig-
nificant negative correlation between D-ROMS
and the cognitive performance was demonstrated
in this study.
In order to better understand the age-related
oxidative stress and to evaluate the correspon-
dence between systemic and local oxidative stress,
we measured plasmatic levels of ROMS and ex-
haled NO in healthy subjects of different ranges of
age. Possible correlations between ROMS, ex-
haled NO and lung function were analysed.
Moreover, the enrolled subjects underwent
cognitive tests in order to evaluate possible corre-
lations between systemic and/or local oxidative
stress and cognitive impairment.
Material and methods
DESIGN OF THE STUDY
The systemic and local oxidative stress in dif-
ferent age ranges of healthy subjects and its corre-
lation with lung function and cognitive impairment
were investigated.
Subjects
The study population consisted of 30 healthy
high school graduate adults (8 M, 22 F), divided in
three groups on the basis of the age: 1) 10 subjects
aged under 35 years (25.9±4.9 yr), (A), 2) 10 sub-
jects aged between 35 and 60 years (52±5.9) (B),
and 3) 10 subjects over 60 years (67.3±4.6) (C).
All subjects were Caucasians, recruited from
the Respiratory Disease Institute, University of
Foggia. Informed written consent was obtained
from all subjects and the study was approved by
the Institutional Ethics Committee. All subjects
were current non-smoker. Subjects with experi-
enced respiratory symptoms or respiratory dis-
eases and with clinical conditions associated with
major elevation of inflammatory parameters (acute
or chronic viral and bacterial infection, cancer,
connective diseases, inflammatory bowel diseases,
therapy with corticosteroids or immune-modulat-
ing agents, thromboembolic events or surgery in
the preceding six months, endocrine diseases other
that diabetes, liver or kidney diseases) were ex-
cluded.
On the first day, subjects underwent complete
anamnesis, anthropometric and cognitive data and
respiratory function tests collection. On the second
day, subjects underwent exhaled NO measurement
and blood tests. Subjects had not consumed any-
thing and had not undergone any physical activity
in the 60 minutes prior to the exhaled NO mea-
surement.
Pulmonary function testing
Forced expiratory volume in one second
(FEV1) and forced vital capacity (FVC) and the
FEV1/FVC ratio were measured using a spirome-
ter (PK Morgan Ltd., Gillingham, UK). The best
value of three manoeuvers was expressed as a per-
centage of the predicted normal value.
Measurement of exhaled NO
A rapid-response chemiluminescence NO
analyser (NIOX) was used to quantify NO. Two-
point calibrations were performed daily using 5.2-
parts per million calibration gas. Exhaled NO
(FENO) was measured using a previously de-
scribed restricted breath technique, which em-
ployed expiratory resistance and positive mouth
pressure to close the velum and exclude nasal NO,
and a constant expiratory flow of 45 mL/s. Sub-
jects inhaled to total lung capacity, and exhaled
while targeting a constant pressure of 20 mmHg.
Exhalations proceeded until a clear NO plateau of
at least 3s duration was achieved. Repeated exha-
lations were performed until three plateaus agreed
within 5%.
Plasma measurements
Plasma reactive oxygen metabolites measurement
Systemic oxidative stress was measured by the
diacron reactive oxygen metabolites (D-ROM) test
(Diacron International, Italy). Values of D-ROMS
were expressed as Carratelli Units, where 1
U.CARR corresponds to 0.8mg/L H2O2.
Cognitive tests
Cognitive impairment was evaluated by the
Mini Mental State Examination (MMSE) and
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Geriatric Depression Scale (GDS). The use of GDS
also in younger groups of study population was jus-
tified by previous demonstration of validity of
GDS performance compared with other well-vali-
dated and reliable measures of depression, such as
Beck Depression Inventory, also in younger sub-
jects [24].
MMSE is a 30 items test, evaluating orienta-
tion in the time and in the space, memory and cal-
culation ability. A score between 24 and 30 was
considered normal, while a score <24 was consid-
ered pathological.
GDS, a 30 items test, is a basic screening mea-
sure for depression. The score interpretation was:
0-9 normal, 10-19: mild depression, 20-30: severe
depression
The Italian authorised translation of these tests
was self administered, according to the authors
recommendations.
Statistical analysis
Data was expressed as means ± SD. A Mann-
Whitney test was used to compare groups, and cor-
relations between variables were performed using
Pearson’s correlation test. The Significance was
defined as a p value of <0.05.
Results
Subjects characteristics
Anthropometric variables, functional, cogni-
tive and oxidative stress data of studied subjects
are shown in table 1.
Pulmonary function testing
FEV1 showed significant decrease from group
A to group C (3.65±0.16 l/m vs 2.67±0.18 l/m vs
1.89±0.18 l/m) (figure 1). The significant differ-
ence between group A and group B (p<0.001), be-
tween group B and C (p<0.01) and between group
A and C (p<0.0001) was observed. FVC decreased
significantly from group A to group C (4.4±1.0 vs
2.9±0.6 vs 2.3±0.6) (A vs B and A vs C respec-
tively p<0.05 and p<0.01).
Exhaled NO
Concentrations of exhaled NO were progres-
sively higher from group A to group C (5.3±1.0 vs
8.8±1.0 vs 11.0±1.2 ppb) (figure 2). The signifi-
cant difference between groups (A vs B and A vs
C respectively p<0.05; p<0.005) was observed.
ROMs
Concentrations of oxygen free radicals
(ROMS) were progressively increasing from
group A to group C (186.7±7.6 U.CARR vs
273.6±8.4 U.CARR vs 391.7±16.5 U.CARR) (fig-
ure 3). The significant difference between group A
and group B (p<0.0001), between group B and C
(p<0.0001) and between group A and C (p<0.0001)
was identified.
Cognitive tests
No significant difference was observed be-
tween the three groups analysed regarding MMSE
scores (30±0 vs 30±0 vs 30±0). The significant
Table 1. - Anthropometric, functional and systemic inflammation data in the population studied
<35 35-60 over 60
(n=10) (n=10) (n=10)
Age (yr) 26±4.9 52±5.9 67±4.6
FEV1 (l/m) 3.6±0.16 2.6±0.1** 1.8±0.1***
FEV1% 110.3±12.4 100.1±9.7 97.6±1.5
FVC (l/m) 4.4±1 2.9±0.6* 2.3±0.6**
FVC% 109.3±9.8 100.5±6.7 98.8±5.6
FEV1/FVC% 100.1±3.1 100.3±2.6 99.5±3.6
ROMS (U.CARR) 186.7±7.6 273.6±8.4** 391.7±16.5**
NO (ppb) 5.3±1.0 8.8±1.0* 11.0±1.2**
MMSE 30±0 30±0 30±0
GDS 5.8±0.6 8.4±0.6** 11.5±0.8*
Group of 35-60 and over 60 vs <35 = * p<0.05; ** p<0.01; ***p<0.0001. FEV1: forced expiratory volume in 1 second; FVC:
forced expiratory vital capacity; GDS: Geriatric Depression Scale; MMSE: Mini Mental State Examination; NO: exhaled
nitric oxide; ROMS, reactive oxygen metabolites.
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difference was observed regarding GDS scores
(5.8±0.6 vs 8.4±0.6 vs 11.5±0.8) (A vs B: p<0.01;
B vs C:p<0.05; A vs C: p<0.001) (figure 4).
Correlations
The relationships between systemic oxidative
stress markers (plasmatic ROMS), airways oxida-
tive stress markers (exhaled NO), lung function in-
dices (FEV1) and cognitive impairment (MMSE
and GDS) were analyzed. The results are shown in
table (table 2).
The significant positive correlation was ob-
served between plasmatic ROMS and exhaled NO
(r=0.5; p<0.01); furthermore, the significant posi-
tive correlation was observed between plasmatic
ROMS and GDS scores (r=0.7, p<0.0001) and be-
tween exhaled NO and GDS score (r=0.5, p<0.01)
(figure 5).
The significant negative correlation was found
between ROMS and FEV1 (r=-0.77, p<0.0001)(figure 6) and between exhaled NO and FEV1(r=-0.52, p<0.01) (figure 7).
Discussion
Little available data explain our interest in
studying oxidative stress in elderly.
The strong correlation between lung inflam-
mation and oxidative stress in lung diseases is well
known. Inflammation is a protective response to
tissue injury, but if this protection occurs in an un-
controlled manner, it results in a chronic inflam-
mation [25]. During chronic inflammation, the re-
cruitment of inflammatory cells, such as neu-
trophils and phagocytes, leads to ROS release and
tissue damage [12, 26]. In fact, activated neu-
trophils, macrophages and eosinophils generate
O2. -, which is converted into H2O2 by superoxide
dismutase, and hydroxyl radicals, as secondary re-
action. Lung cells in response to ROS release cy-
tokines such as IL-8 and TNF-α that induce neu-
trophil recruitment and activation of transcription
factors, increasing the inflammatory process [27,
28]. ROS are highly reactive and they are able to
deplete intracellular GSH (a physiological antioxi-
dant) and oxidise membrane phospholipids, caus-
ing disruption of its function and cell death. ROS
are also able to damage nuclear DNA and proteins
in many inflammatory lung diseases [29].
Inhaled environmental oxidants may exacer-
bate the underlying inflammation in inflammatory
lung diseases [25]. Ozone, the major component of
air pollution particulates, is able to cause cellular
damage by lipid peroxidation, neutrophil infiltra-
tion, increased airway responsiveness and reduced
pulmonary function also in normal subjects [30].
Moreover, cigarette smoking contains many oxi-
dants and free radicals and it causes airways neu-
trophils and macrophages infiltration, leading to
oxidants release and inflammation [31].
By contrast, poor data is available regarding
airways inflammation and oxidative stress in
healthy subjects during aging, although several pa-
pers investigated systemic inflammation in elderly.
Fig. 1. - FEV1 values in three analysed groups. (Group A: <35 years;
B: >35 and <60 years; C: >60 years).
Fig. 2. - Exhaled NO levels in three analysed groups (Group A: <35
years; B: >35 and <60 years; C: >60 years).
Fig. 3. - ROMS plasmatic levels in three analysed groups (Group A:
<35 years; B: >35 and <60 years; C: >60 years).
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In our previous research, the increase of air-
ways inflammatory markers during aging have
been demonstrated (unpublished data). The aim of
the present study was to identify the correlation
between the progressive increase of systemic and
local oxidative stress during aging, lung function
and cognitive impairment.
The progressive increase of exhaled NO dur-
ing aging was demonstrated, according to the hy-
pothesis that exhaled NO probably reflects under-
lying airways inflammation observed in elderly
[32, 33]. Furthermore, the positive correlation of
exhaled NO with markers of systemic oxidative
stress (ROMS) suggests a common mechanism un-
derlying the systemic and local oxidative stress
and highlights the utility of exhaled NO measure-
ment in airways studies.
In agreement with previous publications, we
demonstrated the progressive decrease of forced
vital capacity (FVC) and forced expiratory volume
in 1 second (FEV1) during aging. The negative
correlation with systemic and airways oxidative
metabolites supports the role of oxidative stress,
due to pollutants and cigarette smoke exposure
during life, in damaging the lung function.
Several studies demonstrated progressive cog-
nitive impairment during aging and they have re-
lated this damage to a progressive increase of the
systemic oxidative stress [34, 35]. The EVA study
showed that subjects with the highest levels of
TBARS (thiobarbituric acid reactant substances,
an indicator of lipoperoxidation) presented the in-
creased risk of cognitive decline, measured using
the Mini Mental Status Examination (MMSE)
[36]. Negative correlation between cognitive de-
gree and anti-oxidant status was identified in this
study [36]. It is probable that the increased levels
of oxidative stress and/or antioxidant deficiencies
may represent risk factors for cognitive decline,
that is a major component of age-related dement-
ing diseases and that can share the same patholog-
ical pathways with neurodegenerative processes
and cerebrovascular lesions [37].
These studies can be limited by the population
sample: in fact the enrolled patients were often in
the age-range between 60 and 80 years and the fol-
low up of three or four years was done. To our
knowledge, no sufficient data is available on the
progressive cognitive impairment during aging
from younger to older subjects. In contrast with
previous studies, analysing the cognitive impair-
ment degree with MMSE, we found no differences
in MMSE score between three groups, although
the progressive increase of systemic and airways
oxidative stress was observed. We have tested cog-
nitive impairment in healthy elderly subjects also
using GDS; elevated GDS scores were observed in
many studies evaluating depressive moods in pa-
tients affected by several diseases such as COPD,
which is known to be related to oxidative stress. In
these studies often worse respiratory function was
related to higher GDS scores. We have observed in
healthy subjects progressive increase of GDS val-
ues during aging and a correlation between GDS
scores and systemic and local oxidative stress;
however most of the subjects were in the mild
stage of depression (GDS score: 10-19) and none
of the studied subjects were included into the “se-
vere depression” group (GDS score ≥20). We
could suggest that this result is due to the early on-
set during life of local and systemic oxidative
stress, that could be able to influence the cognitive
functions in the younger subjects jet, also having a
less strong effect than COPD. However a limita-
tion of this hypothesis is the small number of
analysed subjects in our study; moreover an other
confounding factor could be that in the available
studies the short form (15 items) of GDS is fre-
quently used both on ill and healthy subjects; this
questionnaire is based on a different score system
(a score >5 points is suggestive of depression and
a score >10 is almost always depression) and it is
therefore difficult to compare the results.
The progressive score increase of GDS, and
the significant correlation between oxidative stress
and depression degree during aging are demon-
strated by our study.
Major depressive disorder (MDD) and clinical
depression are known to be related to oxidative
stress and inflammation. It was suggested that
stressors and cytokines share a common ability to
impair neuronal plasticity and at the same time al-
Table 2. - Correlations between systemic oxidative
stress markers (plasmatic ROMS), airways oxidative
stress markers (exhaled NO), lung function indices
(FEV1) and cognitive impairment (MMSE and GDS)
MMSE GDS FEV1
Exhaled NO ns R=0.5** R=-0.52**
ROMS ns R=0.7*** R=-0.77***
* p<0.05; ** p<0.01; ***p<0.0001. FEV1: forced expiratory
volume in 1 second; GDS: Geriatric Depression Scale;
MMSE: Mini Mental State Examination; NO: exhaled 
nitric oxide; ROMS: reactive oxygen metabolites.
Fig. 4. - GDS scores in three analyzed groups (Group A: <35 years;
B: >35 and <60 years; C: >60 years).
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tering neurotransmission, ultimately contributing
to depression [38, 39]. On this basis, it is possible
to suggest that oxidants level and oxidants-anti-ox-
idants balance alterations are, at least in part, re-
sponsible also for the depression increase observed
in healthy subjects during aging [40]. In accor-
dance with this data, our results not only show a
correlation between oxidative stress and airway in-
flammation in healthy subjects during aging, but
they also could suggest a role of oxidative stress in
progressive cognitive impairment. Our data, which
is not conclusive due to limitations of the study,
such as the small number of enrolled patients, is
nevertheless suggestive of the importance of ox-
idative stress in cognitive functions and new stud-
ies are necessary in order to clarify the mecha-
nisms underlying these correlations in healthy ag-
ing individuals.
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